Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Irritable Bowel Syndrome, September 2026 Free Subscription Abstracts Retrieve all available abstracts of the following 41 articles: HTML format

Single Articles

1. XU Y, Wu W, Zhang Z, Dong Y, et al
   Si-Si-Gu-Ben granules alleviate diarrhea-predominant irritable bowel syndrome by modulating gut microbiota and suppressing the TLR4/NF-kappaB pathway: A combined clinical and animal study.
   J Ethnopharmacol. 2026 Sep 4:122352. doi: 10.1016/j.jep.2026.122352.
   PubMed    
   Abstract available
   
   

2. KHALIL C, Suchak KK, Amaro IF, Krut Z, et al
   Patients' Real-World Experiences With Pharmacologic Therapies for Irritable Bowel Syndrome With Constipation: A Mixed-Methods Analysis and Classification of Social Media and E-Forum Posts.
   Neurogastroenterol Motil. 2026;38:e70432.
   PubMed    
   Abstract available
   
   

3. GROEN SR, Vork L, Weerts ZZRM, Mujagic Z, et al
   Phenotyping Increased Urge to Defecate in Irritable Bowel Syndrome: Analysis of Symptom, Sensory, and Psychological Profiles.
   United European Gastroenterol J. 2026;14:e70287.
   PubMed    
   Abstract available
   
   

4. LIU N, Huang Y, Wang Y, Qiao H, et al
   Pathogenesis and therapeutic strategies for irritable bowel syndrome: an integrated perspective from dynamic balance theory of Chinese medicine.
   Front Med (Lausanne). 2026;13:1823683.
   PubMed    
   Abstract available
   
   

5. AN L, Luan M, Yang Y, Wang S, et al
   The algorithmic epistemic inversion in gastroenterology: how social media and psychological vulnerability fuel secondary risks in IBD and IBS management.
   Front Public Health. 2026;14:1871219.
   PubMed    
   Abstract available
   
   

6. DICHTER J
   Bile Acid Metabolism as a Unifying Readout for Diet, Microbiome Function, and Gastrointestinal Disease.
   FASEB J. 2026;40:e72273.
   PubMed    
   Abstract available
   
   

7. ZHANG Z, Holton M, Ferrer DM, Tripp AD, et al
   Metagenome-scale modeling to assess microbiome metabolic complementarity for precision microbiota transplantation therapies.
   Gut Microbes. 2026;18:2725403.
   PubMed    
   Abstract available
   
   

8. JIA Z, Gu X
   Initiating multi-strain probiotics is associated with clinically meaningful symptom relief, better quality of life, and fewer treatment escalations in IBS-D/IBS-M: a Chinese real-world propensity-matched cohort study.
   Front Med (Lausanne). 2026;13:1900112.
   PubMed    
   Abstract available
   
   

9. SUN X, Lin Q, Xu Y, Hu P, et al
   Ameliorating Effects and Autonomic Mechanisms of Transcutaneous Auricular Vagus Nerve Stimulation on Abdominal Pain in Patients With Functional Dyspepsia and Irritable Bowel Syndrome.
   Neurogastroenterol Motil. 2026;38:e70224.
   PubMed    
   Abstract available
   
   

10. JO D, Farahmand Y, Friedman K, Shepherd JM, et al
    Relationships Between Risky Substance Use and Irritable Bowel Syndrome (IBS) Severity, Mental Health, and Smoking-Related Processes in Adults with IBS Who Smoke.
    J Dual Diagn. 2026 Sep 1:1-13. doi: 10.1080/15504263.2026.2726789.
    PubMed    
    Abstract available
    
    

11. KIM M, Vuong HE
    Indole-AhR signaling shapes emotional regulation.
    Cell Rep. 2026;45:117747.
    PubMed    
    Abstract available
    
    

12. QIU YN, Zhong BH, Zhang HH, Dai SX, et al
    Dynamic precision therapy in chronic gastrointestinal diseases: A focus on gastroesophageal reflux disease and inflammatory bowel disease-A narrative review and conceptual perspective.
    Ther Adv Gastroenterol. 2026;19:17562848261483778.
    PubMed    
    Abstract available
    
    

13. YANG F, Tian D, Zhang Y, Xia Z, et al
    Traditional Chinese medicine formulation Chang-Kang-Fang restores gut-brain homeostasis in IBS-D via the Lactobacillus johnsonii-indole-3-lactic acid-aryl hydrocarbon receptor/interleukin-22 axis.
    Phytomedicine. 2026;161:158786.
    PubMed    
    Abstract available
    
    

14. WANG Y, Li P, Dong Y, Zhang X, et al
    Neuroimmune regulation of visceral pain: roles of microglia, purinergic signaling, and neuroinflammation.
    Front Immunol. 2026;17:1934162.
    PubMed    
    Abstract available
    
    

15. BLAKE S, Cannon H, Shantikumar S
    The Association Between Attention-Deficit Hyperactivity Disorder and Gastrointestinal Symptoms: A Systematic Review and Meta-Analysis.
    J Atten Disord. 2026 Sep 10:10870547261469626. doi: 10.1177/10870547261469626.
    PubMed    
    Abstract available
    
    

16. TAO W, Yu Y, Huang X, Huang J, et al
    Global research trends in enteric nervous system and gut microbiota: a bibliometric analysis (2005-2025).
    Front Cell Infect Microbiol. 2026;16:1806356.
    PubMed    
    Abstract available
    
    

17. ABDELSHAFI A, Abdelhamid ZG, Osama B, Mohammed YA, et al
    Severity of irritable bowel syndrome and its correlates among Middle East and North African medical students: a multicentric cross sectional study.
    Sci Rep. 2026;16:28211.
    PubMed    
    Abstract available
    
    

18. LACY BE, Petrov JC, Castillo PR
    Sleep and Disorders of Gut-Brain Interaction.
    Gastroenterol Hepatol (N Y). 2026;22:362-370.
    PubMed    
    Abstract available
    
    

19. PEREYRA F, Schlottmann F, Salvatori C, Smolarczuk A, et al
    Effectiveness of a FODMAP-Based, Coach-Supervised, and Peer-Supported Lifestyle Program in Reducing Gastrointestinal and Extraintestinal Symptoms in Irritable Bowel Syndrome.
    Gastro Hep Adv. 2026;5:101087.
    PubMed    
    Abstract available
    
    

20. SILVA H, Knowles SR, Porter J, Barrett J, et al
    Disordered Eating Behaviors Many Years After Education in a Low FODMAP Diet in Patients With Irritable Bowel Syndrome.
    JGH Open. 2026;10:e70467.
    PubMed    
    Abstract available
    
    

21. RAHOU I, Gehrmann T, Ahannach S, Allonsius CN, et al
    Citizen science reveals comorbidities in endometriosis with no shift in vaginal microbiome composition.
    NPJ Womens Health. 2026;4:28.
    PubMed    
    Abstract available
    
    

22. GAO H, Schneider CV, Seibel T, Zhang C, et al
    No robust cortical morphometry differences and limited morphometry-phenotype associations in a UK Biobank irritable bowel syndrome phenotype.
    Neuroimage. 2026 Sep 8:122207. doi: 10.1016/j.neuroimage.2026.122207.
    PubMed    
    Abstract available
    
    

23. PIHLAJAMAKI H, Aitokari L, Nissinen K, Lehtonen S, et al
    Other special diets in addition to gluten-free diet are common among youth with celiac disease, but are not associated with overall well-being or treatment success.
    Nutr Health. 2026 Sep 7:2601060261484265. doi: 10.1177/02601060261484265.
    PubMed    
    Abstract available
    
    

24. ABI NASSIF M, El-Chammas K, Graham K, Sahay RD, et al
    Insurance Authorizations in Pediatric Disorders of Gut-Brain Interaction Treated With Auricular Neuromodulation: A Tertiary Center Experience.
    Neuromodulation. 2026 Jul 20:S1094-7159(26)01309.
    PubMed    
    Abstract available
    
    

25. CHANG L, Staller K, Houghton LA, Yerneni N, et al
    Effect of Age and Age-Defined Menopausal Status on Linaclotide Efficacy and Safety in Adults With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation: Post Hoc Analyses of Phase 2b/3 Studies.
    Neurogastroenterol Motil. 2026;38:e70429.
    PubMed    
    Abstract available
    
    

26. NAKAYA K, Nakaya N, Kogure M, Hatanaka R, et al
    Mortality in Irritable Bowel Syndrome: The Tohoku Medical Megabank Project Community-based Cohort Study.
    J Neurogastroenterol Motil. 2026 Sep 4. doi: 10.5056/jnm25142.
    PubMed    
    Abstract available
    
    

27. BIANCO A, Russo F, Prospero L, Laselva G, et al
    Divergent intestinal barrier and neuroimmune responses to supervised exercise across fibromyalgia, irritable bowel syndrome, and their comorbidity phenotypes: a prospective interventional study.
    Front Physiol. 2026;17:1912788.
    PubMed    
    Abstract available
    
    

28. KAUTZ M, Larson DT, Hseih HC, Maves RC, et al
    Post-Infectious Sequelae Following a Shiga Toxin-Producing Escherichia coli Outbreak Among US Marine Corps Recruits.
    Open Forum Infect Dis. 2026;13:ofag569.
    PubMed    
    Abstract available
    
    

29. PRIEGO-PARRA BA, Felix-Tellez FA
    Editorial: Beyond gastrointestinal symptoms: psychosocial implications of disorders of gut-brain interaction.
    Front Med (Lausanne). 2026;13:1965333.
    PubMed    
    
    
    

30. LIN J, Weng Z, Zhang F, Zhou Y, et al
    [Experimental studies on acupuncture-moxibustion for irritable bowel syndrome in the past five years: a literature analysis].
    Zhongguo Zhen Jiu. 2026;46:1554-1561.
    PubMed    
    Abstract available
    
    

31. ANCONA S, Ronchetti AB, Pescio E, Nobili L, et al
    Disorders of Gut-Brain Interaction in Juvenile Fibromyalgia Syndrome: Prevalence, Clinical Characteristics, and Management in a Single-Centre Cohort Study.
    J Rheumatol. 2026 Sep 15:jrheum.2025-1375. doi: 10.3899/jrheum.2025-1375.
    PubMed    
    Abstract available
    
    

32. WANG Y, Zou K, Liu D, Guo Q, et al
    Reproducibility of Published Meta-Analyses on Acupuncture for Irritable Bowel Syndrome.
    J Evid Based Med. 2026 Sep 15:e70188. doi: 10.1111/jebm.70188.
    PubMed    
    Abstract available
    
    

33. LIU G, Li M, Liu J, Li YP, et al
    Engineering Small Extracellular Vesicles for Colon-Targeted Delivery: Microenvironment-Responsive Design, Therapeutic Mechanisms, and Clinical Translation.
    Int J Nanomedicine. 2026;21:635349.
    PubMed    
    Abstract available
    
    

34. DELLSCHAFT N, Alhasani A, Reid JESJ, Hoad CL, et al
    Clinical Trial: Randomised Placebo-Controlled Trial of Methylcellulose and Psyllium Gels on Inulin-Induced Colonic Gas.
    Aliment Pharmacol Ther. 2026 Sep 11. doi: 10.1111/apt.70964.
    PubMed    
    Abstract available
    
    

35. WU J, Thongchuenjit S, Luo X, Yuan H, et al
    Comparison of demographic, clinical, and psychological characteristics among patients with irritable bowel syndrome meeting the Rome clinical, Rome V, and Rome IV criteria.
    Am J Gastroenterol. 2026 Sep 18. doi: 10.14309/ajg.0000000000004207.
    PubMed    
    Abstract available
    
    

36. VECSEI A, Hammer HF, Hammer J
    Lactose sensitivity and malabsorption in functional dyspepsia and functional dyspepsia-irritable bowel syndrome overlap.
    Digestion. 2026 Sep 7:1. doi: 10.1159.
    PubMed    
    Abstract available
    
    

37. BALSIGER LM, Schol J, Raymenants K, Van de Bruaene C, et al
    Individualized targeted exclusion diet based on confocal laser endomicroscopy does not improve irritable bowel syndrome symptoms: a randomized controlled crossover trial.
    Gastroenterology. 2026 Sep 1:S0016-5085(26)07228.
    PubMed    
    Abstract available
    
    

38. WANG A, Sun Y
    Beyond average efficacy: how should patients be matched to gut-directed hypnotherapy for IBS?
    Gut. 2026 Sep 7:gutjnl-2026-340327. doi: 10.1136/gutjnl-2026-340327.
    PubMed    
    
    
    

39. BLACK CJ, Chuah KH
    Global epidemiology of disorders of gut-brain interaction: new insights with Rome V.
    Gut. 2026 Sep 15:gutjnl-2026-340229. doi: 10.1136/gutjnl-2026-340229.
    PubMed    
    
    
    

40. GOYAL MK, Goyal O, Sehgal T, Vuthaluru AR, et al
    What is new in Rome V?: Redefining diagnostic criteria and clinical pathways in disorders of gut-brain interaction.
    Indian J Gastroenterol. 2026 Sep 17. doi: 10.1007/s12664-026-02044.
    PubMed    
    Abstract available
    
    

41. KIM NM, Kim GJ
    Leveraging electronic health records for subtype-dependent directionality in depression and gastrointestinal disease: a retrospective cohort study.
    J Psychosom Res. 2026;211:112994.
    PubMed    
    Abstract available